Bobby Green Accepts Sanction for Violation
of UFC Anti-Doping Policy https://t.co/InKZkG7wPJ— USADA (@usantidoping)
October 7, 2022
Ultimate Fighting Championship lightweight
Bobby
Green will be forced to sit out for another month before he can
compete again.
Advertisement
The U.S.
Anti-Doping Agency announced on Thursday that Green has been
issued a suspension after his positive test for an anabolic steroid
after an out-of-competition test. He was flagged in May 2022, which
is when the six-month suspension will be applied. Green will be
eligible to return to competition starting Nov. 16. While Green
could have received a lengthier sentence, per the agency, his
cooperation and provided documentation reduced it.
Green contested that he purchased a supplement of
dehydroepiandrosterone (DHEA) – a substance that fighters like
Lyoto
Machida have
encountered in past UFC instances – at a local Walmart,
according to TSN’s
report of a past Instagram posting by Green. The substance was
purchased legally as an over-the-counter product from the store.
When USADA concluded its investigation, it found that Green’s level
of fault was less severe to merit a lower suspension.
USADA’s statement regarding Green reads as follows:
”USADA announced today that Bobby Green,
of Apple Valley, Calif. has accepted a six-month sanction for a
violation of the UFC® Anti-Doping Policy.
“Green, 36, tested positive for the presence of an anabolic
androgenic steroid of exogenous origin as the result of a urine
sample collected out-of-competition on May 16, 2022. Exogenous
anabolic androgenic steroids are Non-Specified Substances in the
class of Anabolic Agents and are prohibited at all times under the
UFC Anti-Doping Policy and UFC Prohibited List.
“During an investigation into the circumstances of the case, Green
provided evidence that he purchased dehydroepiandrosterone (DHEA)
as an over-the-counter supplement product at a local retailer. In
the U.S., unlike other countries, DHEA can be legally sold as a
dietary supplement and is different from other anabolic agents that
are regulated as controlled substances. Under the Policy, USADA may
also consider the degree of performance enhancement when
determining the athlete’s level of fault, and in this case,
considered the athlete’s brief use of the supplement.
“Given these factors, USADA determined that Green’s degree of fault
was diminished and that he should receive a reduced period of
ineligibility. He also received a reduction for his Full and
Complete Cooperation.”